TECHNOLOGY PAPER
myADA – Next-generation Anti-Drug Antibody risk prediction
Technology paper on myADA: a next-generation, in-silico tool for accurate Anti-Drug Antibody (ADA) risk prediction powered by advanced MHC class II epitope immunogenicity modeling.
For the best reading experience on mobile, open the PDF in a new tab.